VRAY:NAS (USA) Also trade in: Germany

ViewRay Inc

$ 7.02 0 (0%)
Volume: 774,242 Avg Vol (1m): 1,239,714
Market Cap $: 678.62 Mil Enterprise Value $: 566.55 Mil
P/E (TTM): 0.00 P/B: 4.02
Earnings Power Value -27.14
Net Current Asset Value 1.56
Tangible Book 1.74
Projected FCF 0
Median P/S Value 9.4
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 5/10

Current vs industry vs history
Cash-to-Debt 3.02
Equity-to-Asset 0.57
Debt-to-Equity 0.33
Debt-to-EBITDA -0.85
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.71
DISTRESS
GREY
SAFE
Beneish M-Score 0.05
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -359.19%
WACC 16.19%

Profitability & Growth : 3/10

Current vs industry vs history
Operating Margin % -92.75
Net Margin % -94.36
ROE % -89.45
ROA % -36.20
ROC (Joel Greenblatt) % -145.23
3-Year Total Revenue Growth Rate 98.30
3-Year Total EBITDA Growth Rate -17.40
3-Year EPS w/o NRI Growth Rate 27.60

» VRAY's 30-Y Financials

Financials (Next Earnings Date: 2019-05-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:VRAY

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 334510    SIC : 3842
Compare XKRX:043150 NAS:ARAY HKSE:01789 SZSE:300314 SZSE:300562 NAS:TCMD XKRX:085370 NYSE:IVC XKRX:099190 NAS:NMRD HKSE:01696 OSTO:HANDI XKRX:060280 ROCO:8406 XBRU:IBAB NAS:GNMK AMEX:CVRS HKSE:03600 SZSE:300206 NAS:RTIX
Traded in other countries 6L9.Germany
Address 2 Thermo Fisher Way, Oakwood Village, OH, USA, 44146
ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures and markets radiation therapy systems which provide real-time imaging during radiation treatment. Its product portfolio encompasses The MRIdian linac system, The MRLdian system, Monte Carlo treatment planning system etc. The company holds license for its combination of MRi and radiation therapy technologies.

Ratios

Current vs industry vs history
PB Ratio 4.02
PS Ratio 6.87
EV-to-EBIT -8.23
EV-to-EBITDA -8.69
EV-to-Revenue 6.99
Current Ratio 5.15
Quick Ratio 4.24
Days Inventory 165.32
Days Sales Outstanding 166.21
Days Payable 67.90

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -28.50

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 4.03
Price-to-Median-PS-Value 0.75
Earnings Yield (Joel Greenblatt) % -12.12

More Statistics

Revenue (TTM) (Mil) $ 80.96
EPS (TTM) $ -0.97
Beta 2.28
Volatility % 87.89
52-Week Range $ 4.86 - 13.21
Shares Outstanding (Mil) 96.67

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA N
Higher ROA yoy Y
CFROA > ROA N
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N